Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

528
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
528
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Stages of Infection01:26

Stages of Infection

59.1K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
59.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Is a Test "Genetic?" The Case of Multi-Cancer Early Detection Tests.

Journal of insurance medicine (New York, N.Y.)·2026
Same authorSame journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same author

AI in Healthcare: How Relevant to Medical Risk Selection?

Journal of insurance medicine (New York, N.Y.)·2026
Same author

When Is a Test Genetic? The Case of Multi-Cancer Early Detection Tests.

Journal of insurance medicine (New York, N.Y.)·2026
Same author

Critical Illness Insurance: In Search of Its Identity.

Journal of insurance medicine (New York, N.Y.)·2025
Same author

Autoimmune Diseases following COVID-19 Infection: How Solid is the Evidence?

Journal of insurance medicine (New York, N.Y.)·2024
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Sep 14, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Long Covid in Year 5: Some Progress, Still Many Questions.

Timothy Meagher

    Journal of Insurance Medicine (New York, N.Y.)
    |July 24, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Long Covid, a condition emerging in 2020, shows evolving definitions and potential multiple disease mechanisms. While effective treatments remain elusive, most patients recover over time, with work disability being uncommon.

    Keywords:
    Long Coviddefinitionsdiagnosisdisabilitymechanismstreatment

    More Related Videos

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
    08:41

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

    Published on: November 5, 2021

    2.9K
    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    543

    Related Experiment Videos

    Last Updated: Sep 14, 2025

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
    03:53

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

    Published on: November 10, 2023

    1.4K
    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
    08:41

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

    Published on: November 5, 2021

    2.9K
    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    543

    Area of Science:

    • Infectious Diseases
    • Immunology
    • Neurology

    Background:

    • Long Covid (Post-Acute Sequelae of SARS-CoV-2 infection) emerged in 2020.
    • Significant progress in characterizing Long Covid has been made.
    • Understanding of disease mechanisms and endotypes is advancing.

    Purpose of the Study:

    • To review the current state of Long Covid characterization.
    • To highlight the evolving understanding of Long Covid.
    • To discuss the clinical implications and patient outcomes.

    Main Methods:

    • Literature review and synthesis of current research on Long Covid.
    • Analysis of emerging evidence on disease mechanisms and endotypes.
    • Examination of clinical presentation, prognosis, and impact on disability.

    Main Results:

    • No definitive clinical biomarker or effective therapy for Long Covid has been identified.
    • Evidence suggests multiple endotypes and significant overlap with other post-infectious syndromes like myalgic encephalomyelitis/chronic fatigue syndrome.
    • Most individuals experience symptom resolution over time; recurrent infections contribute to the Long Covid pool.
    • While 20% experience activity limitation, work disability is less frequent than anticipated.

    Conclusions:

    • Long Covid characterization has advanced considerably since 2020.
    • Further research is needed to identify biomarkers and develop effective treatments.
    • The long-term impact on disability appears less severe than initially predicted.